Warning letter
Stanley Specialty Pharmacy Compounding and Wellness Center: warning letter of Jul 24, 2018
FDA warning letter 557711 · Dallas District Office
Key facts
| Reference number | 557711 |
|---|---|
| Company | Stanley Specialty Pharmacy Compounding and Wellness Center |
| Subject | Drug Product/Adulterated |
| Issue date | Jul 24, 2018 |
| Posted date | Jul 24, 2018 |
| Issuing office | Dallas District Office |
| Product type | Drugs |
| Inspection city | Charlotte |
| Inspection ZIP | 28211 |
| Inspection start date | Jul 31, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: